NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹72 Cr | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr | ₹9.80 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹-68 Cr |
| Mar2023 | ₹9.00 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹9.80 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | Positive | |
| Mar2024 | ₹-68 Cr | Negative | |
| Mar2023 | ₹9.00 Cr | -88.16 | |
| Mar2022 | ₹76 Cr | 675.51 | |
| Mar2021 | ₹9.80 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,954.2 Cr | 0.9% | 6.8% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.9% |
6.8% |
0.6% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses